Frequently asked questions

For follistatin gene therapy, treatments are available exclusively through our partner clinic, Proactive Longevity in Cabo San Lucas, a serene and private setting designed for elevated healing. For exosome therapies, our concierge team will connect you with a trusted provider near you.

From the moment you arrive, every detail is curated for comfort, discretion, and transformation. Expect private transportation, a personal concierge, temperature-controlled suites, and a treatment journey that feels more like a luxury retreat than a clinic visit.

You’ll begin with a private consultation and medical screening to evaluate your health status and goals. Our physician-led team will create a personalized treatment plan tailored to your biology and desired outcomes.

Most treatment protocols are completed within one to two days (typically ranging from 1-2 hours), though some guests choose to extend their stay for wellness or tourism. Our concierge can help advise on accommodations, dining, and cultural experiences.

Absolutely. All treatments are conducted by licensed physicians using pharmaceutical-grade biologics in a controlled clinical setting. We follow strict medical protocols, quality assurance, and post-treatment care to ensure your safety and results.

Your healing doesn’t stop when you leave. Our team provides ongoing follow-up, including post-treatment care plans, progress check-ins, and access to your physician for questions or support. We’re here for you every step of the way.

Yes. Teleios is trusted by physicians, entrepreneurs, and high-profile individuals alike. We offer a fully confidential experience, with private booking, secure communications, and white-glove discretion from arrival to departure.

Yes. Many clients choose to bring a partner, friend, or assistant for support. We can accommodate guests in your suite and help arrange additional hospitality services upon request.

Our team is fluent in English and Spanish, and we offer interpretation services if needed. We’re here to make your experience seamless and clear—no matter where you’re coming from.

Yes. Monad is non-lyophilized and sterile-filtered, with full traceability from donor to vial. Each batch undergoes comprehensive quality control, and over 25% of umbilical cords are rejected if they do not meet safety standards

Most healthy adults seeking regenerative care for skin, joints, postpartum recovery, or performance optimization are eligible. A medical consultation will confirm suitability.

Results can vary, typically lasting 3-6 months depending on individual biology, treatment area, and post-care habits.

Through our proprietary processes, each production batch must meet precise specifications for cytokine and growth factor profiles as well as exosome particle counts. Every batch undergoes rigorous validation testing to confirm these specifications are met. Our quality control measures are stringent, and any batch that fails is rejected—ensuring unparalleled potency and consistency in every vial.

We've optimized a manufacturing model that leverages underutilized pharmaceutical facilities and staff. This allows us to maintain rigorous quality protocols and pharmaceutical-grade standards while significantly reducing production costs. The result is a premium product at a more accessible price point.

Monad is enriched with powerful cytokines and proteins, including bFGF for blood vessel formation and tissue repair, G-CSF for white blood cell development, HGF and ICAM-1 for tissue regeneration and wound healing, and VEGF for new blood vessel formation. These components enhance its effectiveness in healing and regeneration.

Monad contains key anti-inflammatory agents such as IL-1Ra, which blocks the inflammatory effects of IL-1, and MCSF R, which supports tissue protection and healing. TIMP1 and TIMP2 help maintain the extracellular matrix and reduce inflammation, contributing to anti-aging by slowing age-related cellular damage.

Our exosome products are developed, manufactured, and regulated as drugs under full FDA oversight and compliance, far exceeding the typical requirements for biologics or tissue-based products.

We maintain comprehensive drug validation reports, including sterility, endotoxin, bioburden, and all required testing to ensure the safety and consistency of each production lot. Full traceability connects every final product back to its original cord source.

A first-of-its-kind, single-dose non-integrating gene therapy that increases your body’s production of Follistatin-344, a protein that helps reduce aging signals, build lean muscle, decrease inflammation, and promote regenerative repair—all without altering your DNA or impacting fertility.

Follistatin works by neutralizing myostatin and activin—two proteins that restrict muscle growth and drive inflammation. By inhibiting these factors, Follistatin creates ideal conditions for the body to regenerate, build lean muscle, and heal more effectively.

No. Stem cell therapy introduces new cells into the body. Follistatin gene therapy, on the other hand, provides genetic instructions that empower your existing cells to repair and regenerate—treating the root cause rather than just the symptoms.

Results vary by individual, but clinical findings at 3 months post-treatment have shown:

↑ 2 lbs lean muscle mass
↓ 0.8% body fat
↓ Biological age by up to 12 years in some patients

 Many also report better energy, performance, and an overall sense of vitality.

Results typically last around 12 months, though biological shifts—especially at the genetic and epigenetic level—may persist longer depending on lifestyle and overall health.

Yes. Follistatin-344 has been evaluated in both primate and human trials with an excellent safety profile, and no negative effects on fertility or immune function. This variant avoids the hormonal disruption sometimes seen with other forms like Follistatin-288.

About one-third of patients may experience a minor increase in LDL cholesterol (approximately 8 ng/dL). This is typically considered clinically insignificant, and is reviewed on a case-by-case basis during your medical consultation.

While innovative, Follistatin gene therapy is built on decades of scientific research. The role of Follistatin in muscle growth and inflammation was first identified in 2001, with subsequent animal and human studies reinforcing its potential. Our current protocol is the result of rigorous development and physician-led application.

Emerging research is promising. A 2021 study (Jajyan) showed a 32.5% increase in lifespan in mice treated with Follistatin. While human longevity data takes time, these results offer compelling early evidence.

Healthy adults looking to improve muscle tone, reduce fat, enhance energy, or proactively slow the aging process. It’s also well-suited for high-performance individuals, biohackers, and those with age-related muscle loss. A medical consultation is required to determine eligibility.

Follistatin gene therapy doesn’t mask symptoms—it reprograms your biology at the cellular level. Unlike creams, supplements, or hormone therapies, this treatment restores the body’s natural ability to regenerate, making it a functional, not just cosmetic, solution to aging.